1.
Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial
by Welsh, Paul
Diabetologia, 2018-05-04, Vol.61 (7), p.1581-1591

2.
Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial
by Gæde, Peter
Diabetologia, 2016-08-16, Vol.59 (11), p.2298-2307

3.
Neutrophil–Lymphocyte ratio is associated with arterial stiffness in diabetic retinopathy in type 2 diabetes
by Wang, Rui-tao
Journal of diabetes and its complications, 2015, Vol.29 (2), p.245-249

4.
Diabetes complications in childhood and adolescent onset type 2 diabetes—a review
by Amutha, Anandakumar
Journal of diabetes and its complications, 2016, Vol.30 (5), p.951-957

5.
Non-albuminuric renal impairment is a strong predictor of mortality in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicent...
by Penno, Giuseppe
Diabetologia, 2018-07-21, Vol.61 (11), p.2277-2289

6.
Glycemic variability and diabetes retinopathy: A missing link
by Hsu, Cherng-Ru
Journal of diabetes and its complications, 2015, Vol.29 (2), p.302-306

7.
Relationship between increased left atrial volume and microvascular complications in patients with type 2 diabetes
by Bonapace, Stefano
Journal of diabetes and its complications, 2015, Vol.29 (6), p.822-828

8.
Plasma NT-proBNP is independently associated with albuminuria in type 2 diabetes
by Zhou, Lingli
Journal of diabetes and its complications, 2016, Vol.30 (4), p.669-674

9.
Diabetes in sub-Saharan Africa
by Mbanya, Jean Claude N, Prof
The Lancet (British edition), 2010, Vol.375 (9733), p.2254-2266

10.
Association between circulating adipocytokine concentrations and microvascular complications in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of con...
by Rodríguez, Alexander J
Journal of diabetes and its complications, 2016, Vol.30 (2), p.357-367

11.
Urine matrix metalloproteinase-7 and risk of kidney disease progression and mortality in type 2 diabetes
by Afkarian, Maryam
Journal of diabetes and its complications, 2015, Vol.29 (8), p.1024-1031

12.
Type 2 diabetes across generations: from pathophysiology to prevention and management
by Nolan, Christopher J, Assoc Prof
The Lancet (British edition), 2011, Vol.378 (9786), p.169-181

13.
Adverse association between diabetic retinopathy and cardiac structure and function
by Aguilar, David, MD
The American heart journal, 2009, Vol.157 (3), p.563-568

14.
Acute and chronic complications of type 2 diabetes mellitus in children and adolescents
by Pinhas-Hamiel, Orit, Dr
The Lancet (British edition), 2007, Vol.369 (9575), p.1823-1831

15.
Data collection on retinopathy as a public health tool: The Hubble telescope equivalent of looking back in time
by Constantino, M.I
Journal of diabetes and its complications, 2017, Vol.31 (4), p.721-725

16.
Serum Amyloid A and Risk of Death and End-Stage Renal Disease in Diabetic Kidney Disease
by Dieter, Brad P
Journal of diabetes and its complications, 2016, Vol.30 (8), p.1467-1472

17.
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
by Robert C Turner
The Lancet (British edition), 1998-09-12, Vol.352 (9131), p.837-853

18.
Prognostic impact of the ankle–brachial index on the development of micro- and macrovascular complications in individuals with type 2 diabetes: the Rio de Janeiro Type 2 Diabetes C...
by Cardoso, Claudia R. L
Diabetologia, 2018-08-15, Vol.61 (11), p.2266-2276

19.
Calpain-10 gene polymorphisms in type 2 diabetes and its micro- and macrovascular complications
by Buraczynska, Monika
Journal of diabetes and its complications, 2013, Vol.27 (1), p.54-58

20.
Anaemia in diabetes : is there a rationale to TREAT?
by THOMAS, M. C
Diabetologia, 2006, Vol.49 (6), p.1151-1157
